Holen Sie sich die Stockscreener-App
9.84
0.61%
-0.06
Schlusskurs vom Vortag:
$9.90
Offen:
$9.97
24-Stunden-Volumen:
153.84K
Relative Volume:
0.32
Marktkapitalisierung:
$1.32B
Einnahmen:
$58.49M
Nettoeinkommen (Verlust:
$-105.04M
KGV:
-7.571
EPS:
-1.2997
Netto-Cashflow:
$-13.78M
1W Leistung:
+2.18%
1M Leistung:
+4.90%
6M Leistung:
+61.31%
1J Leistung:
+93.32%
1-Tages-Spanne:
$9.78
$10.25
1-Wochen-Bereich:
$9.425
$10.49
52-Wochen-Spanne:
$3.30
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
9.84 | 1.33B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
Does Immatics N.V. stock have upside surprise potentialQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Can Immatics N.V. Equity Warrant be the next market leader2025 Key Highlights & Consistent Income Trade Ideas - mfd.ru
Immatics (IMTX) Receives FDA Orphan Status for Melanoma Treatmen - GuruFocus
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Whale Trades: Will Immatics NV Equity Warrant benefit from government policyJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Pharma News: What is the target price for Immatics NV stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Why (IMTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Inflation Data: Is Immatics NV a cyclical or defensive stockQuarterly Trade Summary & Weekly High Return Forecasts - baoquankhu1.vn
Weekly Recap: Will Immatics NV Equity Warrant outperform its industry peersPortfolio Risk Report & Consistent Profit Alerts - baoquankhu1.vn
Loss Report: Will Immatics N.V. Equity Warrant benefit from current market trends2025 Pullback Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Immatics N.V. (NASDAQ:IMTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Should I set a stop loss on Immatics NVWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock trending bullish2025 Price Momentum & Growth Oriented Trading Recommendations - mfd.ru
Can Immatics N.V. Equity Warrant generate free cash flowInsider Selling & Risk Controlled Stock Alerts - mfd.ru
Understanding Momentum Shifts in (IMTX) - Stock Traders Daily
What’s the outlook for Immatics N.V.’s sectorInsider Selling & Long-Term Growth Plans - mfd.ru
Should you buy the dip on Immatics N.V.July 2025 Chart Watch & Fast Gaining Stock Reports - mfd.ru
Highs Report: Can IF Bancorp Inc continue delivering strong returnsEarnings Recap Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Update: Will Immatics NV Equity Warrant benefit from government policyMarket Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Immatics N.V. (IMTX) Investor Outlook: Exploring An 88% Upside Potential In Biotech - DirectorsTalk Interviews
Downgrade Watch: Will Immatics NV Equity Warrant benefit from current market trends2025 Price Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Portfolio Recap: Can LGVN deliver alphaWeekly Trade Analysis & Smart Investment Allocation Insights - baoquankhu1.vn
ImmunityBio Holds Meeting with FDA on Anktiva Application - Intellectia AI
Aug Drivers: Is Immatics NV forming a breakout patternWall Street Watch & Community Shared Stock Ideas - baoquankhu1.vn
AI Stocks: Whats next for Immatics NV Equity Warrant stockCPI Data & AI Driven Price Forecasts - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (IMTX) Movement - Stock Traders Daily
Is Immatics NV a strong candidate for buy and hold2025 Major Catalysts & Intraday High Probability Setup Alerts - baoquankhu1.vn
Immatics NV's (NASDAQ:IMTX) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains - 富途牛牛
Institutional investors own a significant stake of 38% in Immatics N.V. (NASDAQ:IMTX) - Yahoo Finance
How is Immatics N.V. Equity Warrant managing supply chain issues2025 Trade Ideas & AI Powered Buy/Sell Recommendations - bollywoodhelpline.com
Published on: 2026-01-14 16:10:31 - baoquankhu1.vn
Whale Trades: Is Immatics NV Equity Warrant stock trending bullishWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Weekly Earnings: Will Immatics NV Equity Warrant benefit from green energy policiesWeekly Trading Summary & Technical Pattern Alert System - baoquankhu1.vn
Immatics Publishes Updated PRAME-Focused Investor Presentation on January 12, 2026 - TipRanks
Wall Street Zen Downgrades Immatics (NASDAQ:IMTX) to Sell - MarketBeat
History Review: Should I hold or sell Immatics NV stock in 2025Weekly Trade Summary & Consistent Income Trade Recommendations - moha.gov.vn
Why Immatics N.V. Equity Warrant stock could see breakout soon2025 Biggest Moves & AI Forecast Swing Trade Picks - Улправда
Is Immatics N.V. Equity Warrant stock a buy for dividend growthRisk Management & Free Daily Entry Point Trade Alerts - Улправда
Is Immatics N.V. stock a top pick in earnings seasonStock Surge & Accurate Intraday Trade Tips - Улправда
Market Recap: How supply chain issues affect Immatics N.V. stockJuly 2025 Outlook & Expert Verified Stock Movement Alerts - Улправда
Why Immatics N.V. stock remains on buy lists2025 AllTime Highs & High Conviction Buy Zone Alerts - Улправда
How Immatics N.V. stock performs in high volatility marketsJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - Улправда
Can Immatics N.V. Equity Warrant stock reach $100 price targetMarket Volume Report & Smart Investment Allocation Tips - Улправда
Will Immatics N.V. Equity Warrant stock continue upward momentumQuarterly Trade Report & Detailed Earnings Play Strategies - Улправда
Aug Levels: Will Immatics N.V. stock split attract more investors2025 Retail Activity & Free Community Consensus Stock Picks - Улправда
How supply chain issues affect Immatics N.V. stock2025 Buyback Activity & Daily Entry Point Alerts - Улправда
Should I hold or sell Immatics N.V. stock in 20252025 Earnings Surprises & Weekly Top Gainers Trade List - Улправда
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Summary: Is Immatics NV stock a top pick in earnings season2025 Short Interest & AI Based Buy and Sell Signals - moha.gov.vn
Discipline and Rules-Based Execution in IMTX Response - Stock Traders Daily
Immatics price target raised to $17 from $14 at BofA - TipRanks
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):